LIVE FROM THE DATABASETRANSACTIONS 362,430COMPANIES 5,763LATEST TRADE Oct 16UPDATED Oct 17, 12:31 AM
Reporting ownerCIK 0001886575

Stephen F. Betz

19 transactions in one company, from December 26, 2025 to September 1, 2026.

Transactions
191 company
Bought · P
$0open market
Sold · S
$397Kopen market
Net
−$397Knet selling

By company

Where this insider traded.

CompanyTickerTradesBoughtSold
Crinetics Pharmaceuticals, Inc.CRNX19—$397K

All transactions

19 in total, newest filings first.

CompanyTickerInsiderDateCodeSharesPriceValue
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D47,000$41.21$1.9M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D65,000$48.14$3.1M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D87,000$41.49$3.6M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D110,000$65.36$7.2M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D77,000$64.98$5.0M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D15,000$61.81$927K?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D85,000$69.71$5.9M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D60,000$62.39$3.7M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D56,250$59.81$3.4M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D74,540$75.72$5.6M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVSep 1D90,514$83.09$7.5M?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefSep 1D79,650$85.00$6.8M
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefSep 1D58,286$85.00$5.0M
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefMar 16SPLAN4,241$37.77$160K
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefMar 16SPLAN6,371$37.11$236K
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVFeb 23A47,000$0.00—?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefFeb 23A30,000$0.00—
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDERIVDec 26M18,000$0.00—?
Crinetics Pharmaceuticals, Inc.CRNXStephen F. BetzChiefDec 26M18,000$1.91$34K